AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
Status:
Not yet recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram
per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne
vulagris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks
of treatment in facial acne participants